AKT1 and depressive disorder: Depression accompanied by NP: improving neuroinflammation and providing neuroprotection. Irritable bowel syndrome: inhibiting the leptin/LepRb signaling pathway and reducing PI3K/AKT phosphorylation and BDNF expression.